Tag: engineering
-
Home V.R. Therapy Shown to Reduce Back Pain
A virtual reality program conducted at home is shown in a clinical trial to relieve chronic lower back pain intensity and improve daily living more than a sham V.R. program.
-
Electric Pulses Induce Lung Cancer Immune Response
Results of a clinical trial show a lung cancer therapy using highly focused pulses with electrical energy show signs of immune responses that can treat the patients’ tumors.
-
Keeping Conversations Positive with Precision Moderation
Sponsored content removed due to non-payment.
-
Infographic – Little Trust in Companies’ A.I. Use
A poll in the U.S. shows a large majority of Americans who heard of artificial intelligence have very little or no trust that companies will use the technology responsibly.
-
Merger to Form Programmable Nano-Medicines Company
A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties.
-
Coalition to Boost African Ancestry Genomic Data
An historically Black medical college and pharmaceutical industry group began a program to increase the numbers of people of African descent in genomic databases.
-
Organ Chip Devices to Model for Radiation Sickness
The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness.
-
Start-Up Adapts Crispr for Molecular Detection, Raises $40M
A new company is underway that says it adapts the gene editing technique Crispr to make detecting nucleic acid targets like DNA or RNA faster and simpler.
-
High-Speed Biologic Injection Device Shown Feasible
A developer of an auto-injection technology says its device can deliver a biologic drug under the skin in a fraction of the time of conventional syringes.
-
Collapsed Microbiome Biotech Sells Off Assets
A developer of therapies addressing the body’s microbe communities is selling off key assets to another biotechnology company, after problems developed with its lead program.